Stroke and Risk Factors in Antiphospholipid Syndrome.

Yangyi Fan,Yicheng Xu,Sifan Zhang,Xiaodong Song,Zunjing Liu,Wenjun Tu,Chun Li
DOI: https://doi.org/10.3390/jpm14010024
IF: 3.5083
2024-01-01
Journal of Personalized Medicine
Abstract:Stroke is considered one of the most common and life-threatening manifestations of antiphospholipid syndrome (APS), which leads to high mortality and permanent disability. This study investigated the prevalence and the potential risk factors of stroke in APS. We enrolled 361 APS patients retrospectively from 2009 to 2022 at Peking University People's Hospital. Stroke was found in 25.8% (93/361) of the participants. The multivariate logistic regression showed that hypertension, diabetes, livedo reticularis, and other central nervous system involvements were significant related factors for stroke. The use of hydroxychloroquine appeared to relate to a lower incidence of stroke. During a median follow-up of 3.0 years, 11.8% (11/93) of the individuals with a previous stroke developed stroke recurrence, and thrombocytopenia seemed to be a predictor of stroke recurrence.
What problem does this paper attempt to address?